Yuexin Yu

Dr. Yuexin Yu


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2022 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
QZQian Zhang
Qian Zhang
XWXiaolong Wang
Xiaolong Wang
YZYuming Zhang
Yuming Zhang
HLHaiou Lu
Haiou Lu
YYYuexin Yu
Yuexin Yu
Background: This study aimed to identify multiple endometrial receptivity related factors by applying non-invasive, repeatable multimodal ultrasound methods. Combined with basic clinical data, we further established a practical prediction model for early clinical outcomes in Freeze-thawed Embryo Transfer (FET). Methods: Retrospective analysis of clinical data of infertility patients undergoing FET cycle in our Center from January 2017 to September 2019. Receiver operating characteristic (ROC) curve and decision curve analyses were performed by 500 bootstrap resamplings to assess the determination and clinical value of the nomogram, respectively. Results: A total of 2457 FET cycles were included. We developed simple nomograms that predict the early clinical outcomes in FET cycles by using the parameters of age, BMI, type and number of embryos transferred, endometrial thickness, FI, RI, PI and number of endometrial and sub-endometrial blood flow. In the training cohort, the area under the ROC curve (AUC) showed statistical accuracy (AUC = 0.698), and similar results were shown in the subsequent validation cohort (AUC = 0.699). Decision curve analysis demonstrated the clinical value of this nomogram. Conclusions: Our nomogram can predict clinical outcomes and it can be used as a simple, affordable and widely implementable tool to provide guidance and treatment recommendations for FET patients.

23 January 2024 in Frontiers in Endocrinology
Verified
Journal Article
Open access
Chao-Hai DuChao-Hai Du
Chao-Hai Du
YYYuexin Yu
Yuexin Yu
XFXinyue Fan
Xinyue Fan
Background: Oxidative stress (OS) is considered one of the major factors affecting male fertility, and research in this field has seen constant growth year by year. Currently, around 700 relevant papers are published each year, with a trend of further growth. Therefore, this study systematically summarizes the literature published in the last decade from a bibliometric perspective, revealing the dynamic development of the field, identifying research hotspots, analyzing future trends, and providing reference for further research.Methods: Relevant literature on oxidative stress and male fertility was retrieved from the Web of Science Core Collection (WoSCC) database, covering the timespan from 2014 to 2023 and including two types, articles and reviews. CiteSpace and VOSviewer were used for bibliometric analysis, including cluster analysis, co-occurrence analysis, co-citation analysis, and burst analysis of countries/regions, institutions, journals, authors, references, and keywords.Results: This paper studied a total of 5,301 papers involving 107 countries/regions, with China having the highest number of publications (898 papers) and the United States having the highest centrality (0.62). Burst analysis of journal citations revealed the emergence of many new journals (e.g., Antioxidants-Basel, Front Endocrinol) after 2021, indicating continuous expansion and development in this field. Cluster analysis of co-cited references and co-occurring keywords divided the research into areas such as oxidative stress and male infertility, oxidative stress level detection, and antioxidants. The keywords associated with research hotspots shifted from oxidative stress detection, sperm DNA damage, apoptosis, and redox potential to DNA methylation, embryonic development, infection, polyunsaturated fatty acids, and antioxidants.Conclusion: Bibliometric methods provide an intuitive reflection of the development process in the field of oxidative stress and male fertility, as well as the analysis of research hotspots in different periods. Research on oxidative stress and embryonic development, as well as antioxidant health management, may become hotspots in future research.

12 June 2024 in Chinese Medical Journal
Verified
Journal Article
Open access
DZDachun Zhuo
Dachun Zhuo
WXWenze Xiao
Wenze Xiao
YTYulong Tang
Yulong Tang
SJShuai Jiang
Shuai Jiang
CGChengchun Geng
Chengchun Geng
JWJiucun Wang
Jiucun Wang
Iron is indispensable for the viablility of nearly all living organisms, and it is imperative for cells, tissues, and organisms to acquire this essential metal sufficiently and maintain its metabolic stability for survival. Disruption of iron homeostasis can lead to the development of various diseases. There is a robust connection between iron metabolism and infection, immunity, inflammation, and aging, suggesting that disorders in iron metabolism may contribute to the pathogenesis of arthritis. Numerous studies have focused on the significant role of iron metabolism in the development of arthritis and its potential for targeted drug therapy. Targeting iron metabolism offers a promising approach for individualized treatment of arthritis. Therefore, this review aimed to investigate the mechanisms by which the body maintains iron metabolism and the impacts of iron and iron metabolism disorders on arthritis. Furthermore, this review aimed to identify potential therapeutic targets and active substances related to iron metabolism, which could provide promising research directions in this field.

15 December 2022 in Frontiers in Endocrinology
Verified
Journal Article
Open access
YCYong Chen
Yong Chen
QZQian Zhang
Qian Zhang
JMJinhui Ma
Jinhui Ma
YYYuexin Yu
Yuexin Yu
Introduction: To map publication trends and explore research hotspots of insulin resistance (IR) in polycystic ovary syndrome (PCOS) study.Methods: With the theme of “Polycystic ovary syndrome” AND “Insulin Resistance”, the key data set of Science Core Literature Collection (WoSCC) web from 2017 to 2021 was extracted and bibliometric analysis was performed. Through VOSviewer v1.6.10 software, the research trend in this field is analyzed visually.Results: 2080 literatures about IR in PCOS from 2017 to 2021 were downloaded. The following basic information was collected for each article: country, author, institution, journal, references. The key words are divided into six categories: (1) The interaction between insulin resistance and chronic inflammation; (2) The relationship between insulin resistance and metabolic syndrome and nonalcoholic fatty liver disease; (3) The interaction between insulin resistance and hyperandrogenemia; (4) The relationship between insulin resistance and dyslipidemia; (5) Metformin may regulate insulin resistance in the treatment of PCOS; (6) The study of serum biomarkers in PCOS patients with insulin resistance.Discussion: The six key words extracted can provide an in-depth perspective for the study of IR in PCOS, and provide valuable information to help researchers identify potential research directions, collaborators and cooperative institutions.

18 January 2021 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Closed access
PDF file
QZQian Zhang
Qian Zhang
ZLZhishu Li
Zhishu Li
YWYinghua Wang
Yinghua Wang
HLHaiou Lu
Haiou Lu
YYYuexin Yu
Yuexin Yu

30 September 2025 in Annals of Medicine
Verified
Journal Article
Open access
PZPanpan Zhao
Panpan Zhao
XWXiliang Wang
Xiliang Wang
QZQian Zhang
Qian Zhang
YXYinling Xiu
Yinling Xiu
KSKaixuan Sun
Kaixuan Sun
YYYuexin Yu
Yuexin Yu
Gonadotropin-releasing hormone (GnRH) antagonist and long-acting GnRH agonist regimens are commonly employed for ovarian stimulation in women undergoing in-vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI), but their relative efficacy in improving pregnancy outcomes remains controversial. Previous studies has yielded conflicting results, leaving clinicians and researchers uncertain about which protocol is more favorable. Given the high prevalence of infertility and the importance of improving pregnancy outcomes for these patients, understanding the differences in the efficacy of these two protocols is crucial. Therefore, our study aims to conduct a direct comparison of pregnancy outcomes between patients using GnRH antagonist protocol or long-acting GnRH agonist protocol. This retrospective study included 575 women with primary infertility who underwent IVF/ICSI at our hospital between January 2021 and December 2022. The study included 501 women who underwent the GnRH antagonist protocol and 74 who underwent the long-acting GnRH agonist protocol. The investigated outcomes included biochemical pregnancy, clinical pregnancy, abnormal pregnancy, miscarriage, and live birth rates. Univariate analysis found no significant differences between the GnRH antagonist and long-acting GnRH agonist protocols for biochemical pregnancy rate, clinical pregnancy rate, abnormal pregnancy rate, and miscarriage rate, whereas the GnRH antagonist protocol was associated with a lower live birth rate than the long-acting GnRH agonist protocol. After adjusting for potential confounding factors, no significant differences were found between the two protocols for biochemical pregnancy, clinical pregnancy, abnormal pregnancy, miscarriage, and live birth rates. Our study results show that the GnRH antagonist and long-acting GnRH agonist protocols yielded comparable outcomes in terms of pregnancy outcomes. Further large-scale prospective studies are required to confirm these findings.